I'll be sure to look at it because I want to read through it myself.
Thank you.
You also mentioned that we don't have a lot of pharmaceutical companies in Canada, and you'd love to see more. I think really great examples for ensuring that we retain our IP in Canada do come out of the pharmaceutical world. For example, penicillin and Ozempic were both Canadian inventions, but we didn't retain the IP and didn't see the economic impact.
I appreciate my colleagues' questions, as well, about Canadians being unsure of AI and what the future holds. IP retention, in the future, is a very critical component to ensure that we see the economic impact of AI and digital innovation moving forward.
Do you see a strong strategy and plan, right now, from the scientific standpoint, to ensure that our universities and researchers are educating our entrepreneurs and developers on the importance of IP retention for Canadian economic impact?